10h
Stocktwits on MSNMineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last WeekThe clinical-stage biopharmaceutical company saw the highest jump in retail interest after reporting positive topline data ...
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
SWTX's desmoid tumor drug, Ogsiveo, is driving its top line. The recent FDA nod for Gomekli to treat a rare tumor diversifies its commercial portfolio.
During her 35-year career in medicine, Dr. Freda Lewis-Hall has been on the frontlines of health care as a clinician, researcher, and leader in the biopharmaceuticals and life sciences industries. An ...
Over the last 7 days, the United States market has dropped by 4.4%, yet it has risen by 7.5% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying high ...
Ogsiveo's net product revenues were $172 million in 2024. Last month, the FDA approved SpringWorks’ MEK inhibitor, Gomekli (mirdametinib) for the treatment of adult and pediatric patients 2 ...
SpringWorks Therapeutics stock opened at $50.88 on Thursday. The company’s 50 day simple moving average is $45.24 and its 200-day simple moving average is $39.04. The company has a market ...
Guggenheim analyst Michael Schmidt maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report) yesterday and set a price target of $57.00. The company’s shares ...
Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Meiragtx Holdings (MGTX – Research Report) today and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results